The Pharmacy Times® Flu resource center provides information about early symptoms of the flu and the array of therapies in development intended to treat it as it progresses. Additionally, learn more about the data coming directly from the most widely attended pharmacy conferences and meetings, updated clinical trial listings, and other resources.
Pharmacists will likely encounter increased demand for the influenza vaccine during the 2020-2021 flu season because of the widely recognized value of this preventive health measure, and the anticipated continued circulation of the severe acute respiratory syndrome coronavirus 2.
The latest update from the CDC incorporates evidence that informs the duration of isolation and precautions recommended to prevent transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to others while limiting unnecessary prolonged isolation and unnecessary use of laboratory testing resources.
The findings indicate that front-line health care workers are at high risk for COVID-19 and that many health care workers with the virus may not have typical symptoms of a respiratory infection, according to the study authors.
Researchers conducted an online study with 371 participants who viewed a COVID-19 screening session between a hotline agent, chatbot or human, and a user with mild or severe symptoms, according to a press release.
The Pharmacy Times® Flu specialty page serves as a hub for all clinical news and articles related to the contagious respiratory condition. Additionally, the flu specialty page provides multiple condition-specific resources, ranging from atherosclerosis and chronic angina to heart failure and stroke prevention.